Danube is plain wrong! His hypothesis is totally flawed, and his reasoning is not rational.
If we are going to talk about negative factors for BMN, they are:
1] Like it or not, the Savanah issue is a downer
2] The JORC was not well received
3] The general market is poor
4] BMN is a GREAT stock to short
5] There are "players" out there screwing around the SP
5] losses lead to negative sentiment ... leads to sellers
But that is IT!!
This bullcrap from Danube is just that! It is not rational & shows his lack of understanding of large tonnage/low grade deposits. It is NOT the value per tonne you look at ... that is plain moronic! It is the cost to produce per lb ... with BMN that is just $22 - VERY economical.
The Scoping study cost p/lb incorporates:
1] geology
2] metallurgy
3] depth of resource
4] bulk mining methods
5] ease of extraction
6] methods of extraction
7] available infrastructure
8] cost of infrastructure
9] ease of shipping
and more
Now are any of you going to listen to an emotional Danube who keeps raving about $/tonne ... OR, are you going to listen to Coffey Mining, INDEPENDENT experts hired to evaluate the economics of Goanikontes, and who have ALREADY proved them themselves quite clearly to be conservative with the last JORC?
Get real!
Now sure, sell if want. I feel for those that bought at higher prices. But sell for the RIGHT reason & not some emotional claptrap that makes no sense.
But any that have actually done any research will know where BMN will trading at by years end
cheers
(I think Danube has me on ignore because I ripped into him in past times on his poor reseach & judgment ... too sad)
- Forums
- ASX - By Stock
- BMN
- lets get this straight
lets get this straight
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BMN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.19 |
Change
-0.010(0.31%) |
Mkt cap ! $553.6M |
Open | High | Low | Value | Volume |
$3.21 | $3.23 | $3.10 | $1.714M | 542.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 609 | $3.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.97 | 3237 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 609 | 3.340 |
1 | 601 | 3.320 |
2 | 3219 | 3.280 |
3 | 173 | 3.180 |
5 | 12021 | 3.170 |
Price($) | Vol. | No. |
---|---|---|
3.020 | 394 | 1 |
3.100 | 1735 | 4 |
3.190 | 320 | 3 |
3.200 | 2345 | 1 |
3.220 | 5000 | 1 |
Last trade - 15.59pm 15/07/2024 (20 minute delay) ? |
Featured News
BMN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online